ICMR - NIRBI


ICMR - National Institute for Research
in Bacterial Infections

आईसीएमआर - राष्ट्रीय जीवाणु संक्रमण अनुसंधान संस्थान

Department of Health Research, Ministry of Health and Family Welfare, Government of India
स्वास्थ्य अनुसंधान विभाग, स्वास्थ्य और परिवार कल्याण मंत्रालय, भारत सरकार
WHO Collaborating Centre For Research and Training On Diarrhoeal Diseases

BETI BACHAO BETI PADHAO
G20

  English   |   हिंदी           

NICED : Scientists

  1. NICED
  2. Scientists
Dr. Suman Kanungo

Dr. Suman Kanungo

Dr Suman Kanungo is a Research Officer in the division of epidemiology in National Institute of Cholera and Enteric Diseases in Kolkata. He joined the institute in April 2008. Before that he worked as a Research coordinator in Kolkata for International Vaccine Institute, Seoul, Korea, an UNDP chartered research institute, engaged in translational research as well as basic research in the field of infectious diseases. After graduating in Medicine in 1991 from Calcutta University, he completed his internship in 1992 and training in Internal Medicine and Chest Medicine in S.S.K.M. hospital (IPGMER) in Kolkata. He completed his post graduate Diploma in Industrial Hygiene in 1995-96 and joined Chittaranjan National Cancer Research Institute in Kolkata and worked there as Clinical registrar in the dept of medical oncology since 2003. In 2003 He joined NICED as consultant Epidemiologist in NICED-IVI collaborative project on diseases surveillance randomized clinical trial of Vi polysaccharide vaccine and bivalent whole cell oral cholera vaccine among 110000 urban slum population to study the disease burden and the efficacy of those vaccines in endemic area like India. He also availed the Fogarty fellowship under AITRP (AIDS Research Training Program) and obtained training in epidemiology in University of California, Los Angeles in 2005 - 2006.

In early part of his carrier, as a clinician, his job responsibilities include management of patients admitted in the department of Internal Medicine and chest unit as well as attending patients in out patient department. While in CNCI, he was engaged in Specific clinical management of patients admitted in the department of medical oncology of the hospital and running the daily out patient department and conducting clinical trials.

After moving to NICED, he is mainly engaged in conducting several field trials, conducting demographic studies and identifying potentials predictors of risk factors for enteric and other diarrhoeal diseases in urban slum setting. He was responsible protocol designing, implementation of operating procedure, adherence to Good Clinical Practice (GCP) and training of the field personnel His special interest in the field of public health is clinical and epidemiological trials, both phase II and III and disease surveillance, with special reference to the outbreak pattern of Vibrio cholerae.. At present he is working as co investigators in some collaborative studies like placebo-controlled, double-blind, single oral dose study to determine the safety and immunogenicity of typhoid vaccine (oral live S. typhi (Ty2 aroC?ssaV?)) in healthy paediatric and adolescent subjects, aged 2 to 17 years inclusive, who reside in the official slums of Kolkata, in collaboration with International Vaccine Institute and Surveillance for dengue fever in eastern Kolkata, West Bengal, India in collaboration with Paediatric Dengue Vaccine Institute. He is also a co investigator in phase II trial of a live oral cholera vaccine in collaboration with Department of Biotechnology, India.

He is a life member of Indian Medical Association, and Indian Public health Association.

General Information
Name Dr. Suman Kanungo
Designation Scientist F
Educational Qualification MBBS, DIH, PhD
Date of joining ICMR 11 April 2008
Date of joining present post 01 Sep 2022
Discipline Epidemiology
Email : kanungos.niced@gov.in  , sumankanungo@gmail.com
   
Academic Qualification:  
Graduation MBBS
Post Graduation DIH (Post Graduate Diploma in Industrial Hygiene)
Doctoral P hD (Physiology)

Profile

Research Experience

Being an epidemiologist and public health specialist I have been working on disease burden estimation and have been involved evaluation of vaccine efficacy and effectiveness in endemic settings for more than 20years. My work on cholera, typhoid and rotavirus and COVID-19 led to policy translation and was taken up by the public health care delivery system in India. I have conducted several national and international collaborative projects.I have also worked on environmental surveillance for typhoid, and rational use of drugs, especially the use of antibiotics in tertiary care hospitals in India, and could show the gap in prescribing patterns in tertiary care, which calls for strengthening of Antimicrobial Stewardship program. My studies, in addition to establishing evidence to support the inclusion of Rota viral vaccines in the national immunization schedule, demonstrated for the first time that the two existing vaccines (Rotavac & Rotasiil) can be used interchangeably for regular immunization.

My recent work on cholera disease burden assessment using a seroepidemiological approach established a feasible, sustainable alternative method for cholera surveillance, as well as the establishment of sentinel monitoring sites in high cholera burden areas to supplement India's current cholera surveillance system.
Currently, I am working on the implementation of oral cholera vaccine using state health machinery in a selected district of West Bengal to assess the impact, in collaboration with Govt. of West Bengal. I am also conducting randomized clinical trials on JE vaccine interchangeability, single dose of HPV vaccine as well as efficacy of Dengue vaccine 
 

Research Interests

My research interest and area of work is public health epidemiology and randomized controlled trials, with special reference to bacterial infections and antimicrobial resistance. Health system research is another area of work where I am involved.

Memberships

  1. Life member: Indian Medical Association
  2. Life member: Indian Science Congress Association since 2004
  3. Life member: Indian Public Health Association and Past Joint Secretary, West Bengal Chapter 2015-2017
  4. Joint Secretary, Indian Public Health Association 2016-2018
  5. Joint Editor, Indian Journal of Public Health 2023 - 2025

Awards

  1. Awarded Fellowship, The National Academy of Sciences, India ( FNASc)
  2. Awarded Fellowship, Indian Public Health Association ( FIPHA)
  3. Awarded Fellowship, West Bengal Academy of Science & Technology (FAScT)
  4. Awarded Membership, National Academy of Medical Sciences, New Delhi( MAMS)
  5. Awarded best paper titled Kanungo S, Chatterjee P, Bavdekar A, Murhekar M, Babji S, Garg R, et al. Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial. The Lancet Infectious Diseases. 2022 Aug 1;22(8):1191-9.ICMR at the ICMR- Intramural and Innovation Summit 2023
  6. Awarded fellowship and travel grant for 5th International Advanced Course of Vaccinology in Asia Pacific Regions, by International Vaccine Institute, Seoul Korea May 9-14th, 2005
  7. Awarded Fellowship of Fondation Meriuex, France for the course and CME on Advanced Vaccinology Course in Annecy, France in 2010
  8. Awarded Fogarty-NIH Fellowship under AITRP program in UCLA, USA in 2005
  9. Awarded travel grant and Fellowship for Advanced Vaccinology Course in South Africa (Afro-ADVAC) in Sep 2016
  10. Awarded travel grant to participate and present paper in 14th International Rotavirus Symposium in Bali, Indonesia (March 14 -16th, 2023)


Projects

Extramural

Principal Investigator

  1. A Open Labeled Controlled Trial To Evaluate The Immune Response Of A Boosting Regimen With Shanchol A Killed Whole Cell Oral Cholera Vaccine (WC-OCV), In Previously Immunized Children And Adults In Eastern Kolkata, India funded by International Vaccine Institute, Seoul, Korea (2012)
  2. The effects of a probiotic fermented milk drink, on the intestinal microbiota and intestinal environment in both young and elderly healthy individuals in an urban community in Kolkata India. Funded by Okayama University, Okayama, Japan (2012 - 2013)
  3. Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccine in India, in collaboration with International Vaccine Institute, Korea and University of Virginia, USA (2012- 2016)
  4. Assessment of perceived health needs and available health care facilities of Malda District. Funded by Indian Council of Medical Research (2013- 2014)
  5. Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Live Attenuated Bovine-Human Rotavirus Reassortant Pentavalent Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants Funded by PATH Vaccine Solution, USA ( 2014-2017)
  6. A Survey of What Research Participants Would Like to Know in Informed Consent in Biomedical Research, funded by Indian Council of Medical Research, New Delhi 2018
  7. Establishing a network of population based influenza surveillance platforms for elderly persons in India, funded by All India Institute of Medical Sciences, New Delhi, India ( 2018-2023)
  8. Immunogenicity and Safety of Rotavac and Rotasiil Administered in an Interchangeable Dosing Schedule among Healthy Indian Infants: A Multicentric, Phase IV, Open-Labelled, Randomized, Controlled Trial (RVICS), funded by Ministry of Health and Family Welfare, Govt. of India ( Coordinated by Indian Council of Medical Research) 2018-2020 Site PI
  9. An Event-Driven,Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Immunogenicity,and Lot-to-Lot consistency of BBV152, a Whole- virion Inactivated SARS-CoV-2 Vaccine in Adults≥18Years of Age funded by Indian Council of Medical Research (2020-2022)
  10. Immune response to the precautionary third dose of COVISHIELD/COVAXIN among healthy adult population: an ICMR Cohort study, India funded by Indian Council of Medical Research ( 2022-ongoing)
  11. Immunogenicity and safety of JENVAC and JEEV vaccines administered for prevention of Japanese encephalitis in an interchangeable dosing schedule among healthy Indian children: A multicentric, phase IV, open-labeled, randomized controlled trial. Funded by ICMR ( 2023-2024)
  12. Determining cause of death profiles among vulnerable communities to improve health interventions: pilot test of a practical verbal autopsy tool funded by CRED-ASED and University of Louvain, Brussels ( 2024-2025)
  13. Antibody Response following One Dose of Cervavac as compared to One Dose of Gardasil Vaccine in Healthy Girls Aged 9-14 Years: A Non-inferiority, Multicenter, Double-blind, Randomized Controlled trial, Funded by ICMR ( 2024-2027)
  14. A Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate the Efficacy, Immunogenicity and Safety of Single dose of Dengue Tetravalent Vaccine, Live Attenuated (Recombinant, Lyophilized) DengiAll of Panacea Biotec Limited in Healthy Indian Adults. Funded by ICMR ( 2024-2027)

Co-Principal Investigator

  1. A randomized controlled trial of the bivalent killed whole-cell oral cholera vaccine in eastern Kolkata, West Bengal, India, in collaboration with International Vaccine Institute, Korea (2008-2011)
  2. Surveillance for dengue fever in Eastern Kolkata, West Bengal, India in collaboration with Paediatric Dengue Vaccine Initiative, Korea (2008-2010)
  3. A randomized controlled trial of recombinant live oral cholera vaccine VA1.4 in Eastern Kolkata, West Bengal, India in collaboration with the Dept. of Biotechnology, India (2009-2011)
  4. Diarrheal Disease in Infants and Young Children in Developing Countries a multi-centric study in collaboration with the University of Maryland, USA (2008-2013)
  5. A randomized controlled trial to evaluate the immunogenicity of the modified killed whole-cell oral cholera vaccine under two alternative vaccination schedules, in collaboration with International Vaccine Institute, Korea. (2010-2013)
  6. District-level Household and Facility Survey 4 .Funded by National Institute of Health and Family Welfare, New Delhi (2012- 2013)
  7. Trial of Candidate Live Oral Cholera Vaccine VA 1.4: A Phase I-II Study to Evaluate the Safety and Immunogenicity in Healthy Adults in Kolkata, India funded by Dept. of Biotechnology, Govt. of India (2012)
  8. Nutritional status of school children in West Bengal: a longitudinal cross sectional survey AND Development of nutritional Surveillance system. Funded by Department of School Education, Govt. of West Bengal (2014-2015)
  9. National Surveillance System for Enteric Fever in India, funded by Christian Medical College ( 2018-2020)
  10. A multi-centric study to estimate the sero-prevalence of dengue, chikungunya, and Japanese encephalitis virus infection in India. funded by the Indian Council of Medical Research, New Delhi ( 2018)
  11. Strengthening laboratory surveillance for pneumococcal meningitis in India to understand the impact of pneumococcal conjugate vaccine (PCV) rollout, funded by Indian Council of Medical Research ( 2018-ongoing)
  12. SaniPath Typhoid- Assessment of Typhoid Exposure Pathways in Low-Income Urban Settings, funded by Emory University Rollins School of Public Health, Atlanta, USA ( 2019-2020)
  13. Evaluation of Prescription Patterns of Drugs for Diarrheal Diseases and Acute Respiratory Infection in Medicine and Pediatrics OPDs of Tertiary Care Hospitals in West Bengal, India, funded by the Indian Council of Medical Research (2019-2021)
  14. A Multicentre, Phase III, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Recombinant BCG VPM 1002 In Reducing Infection Incidence and Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Subjects, funded by Serum Institute of India ( 2020-2021)
  15. Strengthening laboratory surveillance for pneumococcal meningitis in India to understand the impact of pneumococcal conjugate vaccine (PCV) rollout funded by ICMR ( 2018-2025)
  16. Impact of improved diagnostic tools, practices, training and communication on acute fever case management and antibiotic prescriptions for children and adolescents presenting at outpatient facilities in the Community Clinics of ICMR-NICED, India. funded by Foundation for Innovative New Diagnostics Geneva (2021-2023)
  17. Estimation of Vibrio cholerae O1 infection in India: a step towards identification of cholera hotspots funded by Indian Council of Medical Research ( 2020-2022)
  18. A Prospective, Multicenter, Randomized, Active-controlled, Observer-blind, Phase II study seamlessly followed by a Phase III study to evaluate the Safety, Tolerability and Immunogenicity of the candidate HGCO19 (COVID-19 vaccine) in healthy subject. Funded by Gennova Pharmaceuticals, Pune, India ( 2021-2022)
  19. A Phase II/III, Multicenter, Double-Blind, Randomized, Active Controlled Study to evaluate Safety and Immunogenicity of SII Inactivated Salk Polio Vaccine (Adsorbed) in comparison with SII(Serum Institute of India) Licensed Inactivated Poliovirus Vaccine (IPV). Funded by Serum Institute of India ( 2023-2024)

 

Intramural

Principal Investigator

  1. Rationality of prescription habits by the health care providers for treatment of diarrhea especially cholera in urban slums of Kolkata: an observational study (2009 - 2011)
  2. An intervention to improve diarrhea-related knowledge and practices among non-qualified practitioners in an urban slum of Kolkata ( 2012 - 2016)
  3. The role of health system responsiveness in the interplay between perception and treatment-seeking behavior among caregivers of under-5 children in an urban slum of Kolkata, India (2012-2016)
  4. Impact assessment of administering OCV in selected cholera vulnerable district of West Bengal using state health machinery

Co-Principal Investigator

  1. Health care utilization and attitude survey regarding diarrhea among parents of children under 5 years: A cross-sectional community-based study (2010-2012)
  2. A hospital-based clinical study on the efficacy of single dose Azithromycin and standard dose of Norfloxacin in the treatment of cholera in adult (2012-2014)
  3. Assessment of antibiotic use, clinical effectiveness of Point of Care Tests for Acute Undifferentiated Febrile Illness & Acute Respiratory Tract infection through implementation research.

Students

  1. PhD Students : 3

Fellowships:

  1. Fellow: The National Academy of Sciences, India ( Prayagraj) FNASc

  2. Fellow: Indian Public Health Association: FIPHA

  3. Fellow, West Bengal Academy of Sciences and Technology: FWAScT



Travel to foreign countries to attend conference/ meetings

  1. Poster Presentation titled Cholera vaccination in endemic areas: time to redefine dosing interval"
    at the "Cholera Panel Meeting"
    under United States-Japan (US-Japan) Cooperative Medical Sciences Program (CMSP) 50th anniversary celebration and 18th International Conference on "
    Emerging Infectious Diseases (EID) in the Pacific Rim"
    held at Bethesda, MD, USA from 11th - 15th Jan 2016, invited by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH).
  2. Delegate in African Advanced Course of Vaccinology Course (Afro-ADVAC) held in Muldersdrift, Johannesburg, South Africa from 18th -29th Sep 2016.
  3. Attended 10th International Conference on Typhoid and Other Invasive Salmonelloses ,held in Kampala, Uganda from April 4th -6th , 2017.
  4. Presented Poster titled "
    Can Single Dose Based Oral Cholera Vaccine (OCV) Campaigns Combat Cholera Outbreaks in India? Evidence Synthesis for Policy Responses at the 52nd Joint Panel on Cholera and Other Bacterial Enteric Infection, held from 20-24 Feb, 2018 at Prince of Songkla, Hat Yai, Thailand
  5. Delegate at the 5th Annual meeting of the Global Task Force on Cholera Control (GTFCC) and Presented Indian scenario on cholera organized by the Fondation M?ieux at the Fondation Merieux Conference Centre les Pensi?es, in Veyrier du Lac, France, June 13-14, 2018
  6. Poster presentation titled "
    Making the Case for Programmatic Implementation of Oral Cholera Vaccine in Cholera Hotspots of India"
    at the U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) 21st International Conference on Emerging Infectious Diseases in the Pacific Rim, Hanoi Vietnam Feb 26-Mar 01 2019.
  7. Poster presentation titled "
    Water, sanitation and hygiene ( WASH) related practices in an enteric fever endemic slum area in India"
    11th International Conference on Typhoid and Other Invasive Salmonelloses, March 26-28, 2019 at Hanoi, Vietnam
  8. Oral presentation titled "
    Interventional study to improve diarrhoea related knowledge and practices among untrained practitioners in slums of Kolkata"
    at the 15th Asian Conference on Diarrhoeal Disease and Nutrition (ASCODD) in Dhaka, Bangladesh Jan 28-30, 2020.

Publications

2021

  1. Lopez AL, Dutta S, Qadri F, Sovann L, Pandey BD, Bin Hamzah WM, Memon I, Iamsirithaworn S, Dang DA, Chowdhury F, Heng S, Kanungo S, Mogasale V, Sultan A, Ylade M. Cholera in selected countries in Asia. Vaccine 2020 Feb 29; 38 Suppl 1:A18-A24.
    IF: 3.143 CI: 23
  2. Mogasale V, Kanungo S, Pati S, Lynch J, Dutta S. The history of OCV in India and barriers remaining to programmatic introduction. Vaccine. 2020 Feb 29;38 Suppl 1:A41-A45.
    IF: 3.641 CI: 2

2020

  1. Lopez AL, Dutta S, Qadri F, Sovann L, Pandey BD, Bin Hamzah WM, Memon I, Iamsirithaworn S, Dang DA, Chowdhury F, Heng S, Kanungo S, Mogasale V, Sultan A, Ylade M. Cholera in selected countries in Asia. Vaccine 2020 Feb 29; 38 Suppl 1:A18-A24.
    IF: 3.143 CI: 23
  2. Mogasale V, Kanungo S, Pati S, Lynch J, Dutta S. The history of OCV in India and barriers remaining to programmatic introduction. Vaccine. 2020 Feb 29;38 Suppl 1:A41-A45.
    IF: 3.641 CI: 2
  3. Chatterjee P, Kanungo S, Bhattacharya SK, Dutta S. Mapping cholera outbreaks and antibiotic resistant Vibrio cholerae in India: An assessment of existing data and a scoping review of the literature. Vaccine. 2020 Feb 29;38 Suppl 1:A93-A104.
    IF: 3.413 CI: 28
  4. Kumar MS, Bhatnagar T, Manickam, Kumar S, Rade K, Shah N, Kant S, Babu GR, Zodpey S, Kumar CPG, Wesley J, Thangaraj V,Chatterjee P, Kanungo S, et al. National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance Indian J Med Res. 2020 May; 151(5): 419423.
    IF: 1.503 CI: 62
  5. Im J, Islam MT, Kim DR, Ahmmed F, Chon Y, Zaman K, Khan AI, Ali M, Sur D, Kanungo S, Dutta S, Bhattacharya SK, et al. Protection conferred by typhoid fever against recurrent typhoid fever in urban Kolkata. PLoS Negl Trop Dis. 2020 Aug 17;14(8):e0008530.
    IF: 4.411 CI: 10
  6. Murhekar MV, Santhosh Kumar M, Kamaraj P, Khan SA, Allam RR, Barde P, Dwibedi B, Kanungo S, et al. Hepatitis-B virus infection in India: Findings from a nationally representative serosurvey, 2017-18. Int J Infect Dis. 2020 Nov;100: 455-460.
    IF: 3.623 CI: 27
  7. Colston JM, Faruque ASG, Hossain MJ, Saha D, Kanungo S et al. Associations between Household-Level Exposures and All-Cause Diarrhea and Pathogen-Specific Enteric Infections in Children Enrolled in Five Sentinel Surveillance Studies. Int J Environ Res Public Health. 2020 Nov; 17(21): 8078.
    IF: 2.849 CI: 23.
  8. Wang Y, Moe CL., Dutta S, Wadhwa A, Kanungo S, Mairinger W, Zhao Y, Yi Jiang Y, Peter FM . Teunis. Designing a typhoid environmental surveillance study: A simulation model for optimum sampling site allocation. Epidemics. 2020 Jun; 31: 100391
    IF: 3.239 CI: 26

2019

  1. Vidal RM, Muhsen K, Tennant SM, Svennerholm AM, Sow SO, Sur D, Zaidi AKM, Faruque ASG, Saha D, Adegbola R, Hossain MJ, Alonso PL, Breiman RF, Bassat Q, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ahmed S, Qureshi S, Quadri F, Hossain A, Das SK, Antonio M, Mandomando I, Nhampossa T, Accio S, Omore R, Ochieng JB, Oundo JO, Mintz ED, O'Reilly CE, Berkeley LY, Livio S, Panchalingam S, Nasrin D, Farag TH, Wu Y, Sommerfelt H, Robins-Browne RM, Del Canto F, Hazen TH, Rasko DA, Kotloff KL, Nataro JP, Levine MM. Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS). PLoS Negl Trop Dis. 2019 Jan 4;13(1):
    IF: 3.885 CI: 86
  2. Kotloff KL, Nasrin D, Blackwelder WC, Wu Y, Farag T, Panchalingham S, Sow SO, Sur D, Zaidi AKM, Faruque ASG, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ahmed S, Qureshi S, Quadri F, Hossain A, Das SK, Antonio M, Hossain MJ, Mandomando I, Accio S, Biswas K, Tennant SM, Verweij JJ, Sommerfelt H, Nataro JP, Robins-Browne RM, Levine MM. The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicenter Study (GEMS). Lancet Glob Health. 2019 May;7(5):e568-e584. doi: 10.1016/S2214-109X(19)30076-2
    IF: 220 CI: 238
     
  3. Murhekar MV, Kamaraj P, Kumar MS, Khan SA, Allam RR, Barde P, Dwibedi B, Kanungo S, Mohan U, Mohanty SS, Roy S, Sagar V, Savargaonkar D, Tandale BV, Topno RK, Sapkal G, Kumar CPG, Sabarinathan R, Kumar VS, Bitragunta S, Grover GS, Lakshmi PVM, Mishra CM, Sadhukhan P, Sahoo PK, Singh SK, Yadav CP, Bhagat A, Srivastava R, Dinesh ER, Karunakaran T, Govindhasamy C, Rajasekar TD, Jeyakumar A, Suresh A, Augustine D, Kumar PA, Kumar R, Dutta S, Toteja GS, Gupta N, Mehendale SM. Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey. Lancet Glob Health. 2019 Aug;7(8):e1065-e1073
    IF: 220 CI: 129
  4. Panda S, Chatterjee P, Deb A, Kanungo S, Dutta S. Preventing cholera in India: Synthesizing evidences through a systematic review for policy discussion on the use of oral cholera vaccine. Vaccine. 2019 Aug 9. pii: S0264-410X(19)30920-X. doi: 10.1016/j.vaccine.2019.07.029.
    IF: 3.143 CI: 10

2018

  1. Ali M, Kim DR, Kanungo S, Sur D, Manna B, Digilio L, Dutta S, Marks F, Bhattacharya SK, Clemens J. Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera. Int J Infect Dis. 2018 Jan; 66:90-95.  Pubmed
  2. Deen J, Lopez AL, Kanungo S, Wang XY, Anh DD, Tapia M, Grais RF. Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help? Hum Vaccin Immunother. 2018 Feb 1;14(2):495-499.   Pubmed
  3. Sinha A, Kanungo S, Kim DR, Manna B, Song M, Park JY, Haldar B, Sharma P, Mallick AH, Kim SA, Babji S, Sur D, Kang G, Ali M, Petri WA Jr, Wierzba TF, Czerkinsky C, Nandy RK, Dey A. Antibody secreting B cells and plasma antibody response to rotavirus vaccination in infants from Kolkata India. Heliyon. 2018 Feb 1;4(1):e00519.   Pubmed
  4. John J, Bavdekar A, Rongsen-Chandola T, Dutta S; NSSEFI Collaborators, Kang G. Estimating the incidence of enteric fever in children in India: a multi-site, active fever surveillance of pediatric cohorts. BMC Public Health. 2018 May3;18(1):594.   Pubmed
  5. Lopez AL, Deen J, Azman AS, Luquero FJ, Kanungo S, Dutta S, von Seidlein L, Sack DA. Immunogenicity and protection from a single dose of internationally available killed Oral Cholera Vaccine: a systematic review and metaanalysis. Clin Infect Dis. 2018 Jun 1;66(12):1960-1971.    Pubmed
  6. Chatterjee P, Kanungo S, Dutta S. Challenges for programmatic implementation of killed whole cell oral cholera vaccines for prevention and control of cholera: a meta-opinion. Expert Opin Biol Ther. 2018 Sep;18(9):983-988.     Pubmed
  7. Karbwang J, Koonrungsesomboon N, Torres CE, Jimenez EB, Kaur G, Mathur R, Sholikhah EN, Wanigatunge C, Wong CS, Yimtae K, Abdul Malek M, Ahamad Fouzi L, Ali A, Chan BZ, Chandratilake M, Chiew SC, Chin MYC, Gamage M, Gitek I, Hakimi M, Hussin N, Jamil MFA, Janarsan P, Julia M, Kanungo S, Karunanayake P, Kollanthavelu S, Kong KK, Kueh BL, Kulkarni R, Kumaran PP, Kumarasiri R, Lim WH, Lim XJ, Mahmud F, Mantaring JBV 3rd, Md Ali SM, Mohd Noor N, Muhunthan K, Nagandran E, Noor M, Ooi KH, Pradeepan JA, Sadewa AH, Samaranayake N, Sri Ranganathan S, Subasingha W, Subramaniam S, Sulaiman N, Tay JF, Teng LH, Tew MM, Tharavanij T, Tok PSK, Weeratna J, Wibawa T, Wickremasinghe R, Wongwai P, Yadav S; FERCAP Multi-Country Research Team. What information and the extent of information research participants need in informed consent forms: a multi-country survey. BMC Med Ethics. 2018 Sep 15;19(1):79     Pubmed

2017

  1. Kanungo S, Kim DR, Haldar B, Snider C, Nalavade U, Kim SA, Park JY, Sinha A, Mallick AH, Manna B, Sur D, Nandy RK, Deshpande JM, Czerkinsky C, Wierzba TF, Jr WA, Ali M, Dey A. Comparison of IPV to tOPV week 39 boost of primary OPV vaccination in Indian infants: an open labelled randomized controlled trial. Heliyon. 2017 Jan; 3(1):e00223. doi: 10.1016/j.heliyon.2016.e00223. Pubmed
  2. Nayak U, Kanungo S, Zhang D, Ross Colgate E, Carmolli MP, Dey A, Alam M, Manna B, Nandy RK, Kim DR, Paul DK, Choudhury S, Sahoo S, Harris WS, Wierzba TF, Ahmed T, Kirkpatrick BD, Haque R, Petri WA Jr, Mychaleckyj JC.Influence of maternal and socioeconomic factors on breast milk fatty acid composition in urban, low-income families. Matern Child Nutr. 2017 Oct;13(4). doi: 10.1111/mcn.12423. Pubmed
  3. Kanungo S, Chatterjee P. Oral cholera vaccines: exploring the farrago of evidence. Lancet Infect Dis. 2017 Oct;17(10):1012-1013. doi: 10.1016/S1473-3099(17)30420-6. Pubmed
  4. Kulkarni PS, Desai S, Tewari T, Kawade A, Goyal N, Garg BS, Kumar D, Kanungo S, Kamat V, Kang G, Bavdekar A, Babji S, Juvekar S, Manna B, Dutta S, Angurana R, Dewan D, Dharmadhikari A, Zade JK, Dhere RM, Fix A, Power M, Uprety V, Parulekar V, Cho I, Chandola TR, Kedia VK, Raut A, Flores J; SII BRV-PV author group. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants. Vaccine. 2017 Oct 27; 35(45):6228-6237. doi: 10.1016/j.vaccine.2017.09.014.  Pubmed
  5. Deen J, Lopez AL, Kanungo S, Wang XY, Anh DD, Tapia M, Grais RF. Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help? Hum Vaccin Immunother. 2018 Feb 1; 14(2):495-499 Pubmed
  6. Ali M, Kim DR, Kanungo S, Sur D, Manna B, Digilio L, Dutta S, Marks F, Bhattacharya SK, Clemens J. Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera. Int J Infect Dis. 2018 Jan; 66:90-95.  Pubmed
  7. Lopez AL, Deen J, Azman AS, Luquero FJ, Kanungo S, Dutta S, von Seidlein L, Sack DA. Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and meta-analysis. Clin Infect Dis. 2017 Nov 21. doi: 10.1093/cid/cix1039  Pubmed

2016

  1. Mahapatra T, Mahapatra S, Pal D, Saha J, Lopez A, Ali M, Bannerjee B, Manna B, Sur D, Bhattacharya S, Kanungo S. Trials and tribulations of conducting interventional studies in urban slums of a developing country: experiences from Kolkata, India. Hum VaccinImmunother. 2016 Jan 2;12(1):182-6. Pubmed
  2. Ali M, You YA, Kanungo S, Manna B, Deen JL, Lopez AL, Wierzba TF, Bhattacharya SK, Sur D, Clemens JD. Assessing different measures of population-level vaccine protection using a case-control study. Vaccine. 2015 Nov 27; 33(48):6878-83. Pubmed
  3. Desai SN, Akalu Z, Teferi M, Manna B, Teshome S, Park JY, Yang JS, Kim DR, Kanungo S, Digilio L. Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings. Trop Med Int Health. 2016 Feb;21(2):194-201. Pubmed
  4. Ali M ,You YA, Sur D, Kanungo S, Kim DR, Deen JL, Lopez AL, Wierzba TF, Bhattacharya SK, Clemens JD. Validity of the estimates of oral cholera vaccine effectiveness derived from the test-negative design. Vaccine 2016 Jan 20;34(4):479-85. Pubmed
  5. Kanungo S, Mahapatra T, Bhowmik K, Saha J, Mahapatra S, Pal D, Roy R, Bhadra UK, Sarkar K. Patterns and predictors of undiagnosed and uncontrolled hypertension: observations from a poor-resource setting. J Hum Hypertens. 2016 May 19. doi: 10.1038/jhh.2016.30. Pubmed
  6. Sow SO, Muhsen K, Nasrin D, Blackwelder WC, Wu Y, Farag TH, Panchalingam S, Sur D, Zaidi AK, Faruque AS, Saha D, Adegbola R, Alonso PL, Breiman RF, Bassat Q, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ahmed S, Qureshi S, Quadri F, Hossain A, Das SK, Antonio M, Hossain MJ, Mandomando I, Nhampossa T, Acácio S, Omore R, Oundo JO, Ochieng JB, Mintz ED, O'Reilly CE, Berkeley LY, Livio S, Tennant SM, Sommerfelt H, Nataro JP, Ziv-Baran T, Robins-Browne RM, Mishcherkin V, Zhang J, Liu J, Houpt ER, Kotloff KL, Levine MM. The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS). PLoS Negl Trop Dis. 2016 May 24;10(5):e0004729. Pubmed
  7. Park JY, Kim DR, Haldar B, Mallick AH, Kim SA, Dey A, Nandy RK, Paul DK, Choudhury S, Sahoo S, Wierzba TF, Sur D, Kanungo S, Ali M, Manna B. Use of the data system for field management of a clinical study conducted in Kolkata, India.BMC Res Notes. 2016 Jan 9;9(1):20. Pubmed
  8. Kanungo S, Mahapatra T, Bhowmik K, Mahapatra S, Saha J, Pal D, Sarkar K. Diabetes scenario in a backward rural district population of India and need for restructuring of health care delivery services. Epidemiol 2016 6: 224.
  9. Pal D, Kanungo S, Bal B, Bhowmik K, Mahapatra T Sarkar, K.Malnutrition Scenario among School Children in Eastern-India-an Epidemiological Study. Epidemiology (Sunnyvale) 2016, 6:1
  10. Ali M, Debes AK, Luquero FJ, Kim DR, Park JY, Digilio L, Manna B, Kanungo S, Dutta S, Sur D, Bhattacharya SK, Sack DA. Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial. PLoS Med. 2016 Sep 13; 13(9):e1002120. doi: 10.1371/journal.pmed.1002120. e Collection 2016 Sep   Pubmed

2015

  1. Mahapatra T, Mahapatra S, Banerjee B, Mahapatra U, Samanta S, Pal D, Datta Chakraborty N, Manna B, Sur D, Kanungo S. Predictors of rational management of diarrhea in an endemic setting: observation from India. PLoS One. 2015 Apr 7;10(4):e0123479 Pubmed
  2. Kanungo S, Bhowmik K, Mahapatra T, Mahapatra S, Bhadra UK, Sarkar K. Perceived morbidity, healthcare-seeking behavior and their determinants in a poor-resource setting: observation from India.PLoS One. 2015 May 12;10(5):e0125865. Pubmed
  3. Kanungo S, Desai SN , Saha J, Nandy RK , Sinha A , Kim DR, Bannerjee B, Manna B, Jae Seung Yang, Ali M, Sur D, Wierzba TF. An Open label non-inferiority trial assessing vibriocidal response of a killed bivalent oral cholera vaccine regimen following a five year interval in Kolkata, India. PLoSNegl Trop Dis. 2015 May 29;9(5):e0003809. Pubmed
  4. Ali M, You YA, Kanungo S, Manna B, Deen JL, Lopez AL, Wierzba TF, Bhattacharya SK, Sur D, Clemens JD. Assessing different measures of population-level vaccine protection using a case-control study. Vaccine. 2015 Nov 27;33(48):6878-83 Pubmed

2014

  1. Ochiai, R, L., Khan MI, Soofi SB, Sur D, Kanungo S, You YA, Habib MA, Sahito SM, Manna B, Dutta S, Acosta CJ, Ali M, Bhattacharya SK, Bhutta ZA, Clemens JD. Immune response to Vi capsular polysaccharide typhoid vaccine in children (2 - 16 years): results from cluster randomized effectiveness trials in Karachi and Kolkata.Clin Vaccine Immunol. 2014 May;21(5):661-6. Pubmed
  2. Kanungo S, Lopez AL, Ali M, Manna B, Kim DR, Mahapatra T, Holmgren J, Dhingra MS, Weirzba TF, Nair GB, Bhattacharya SK, Clemens JD, Sur D.Vibriocidal Antibody Responses to a Bivalent Killed Whole-Cell Oral Cholera Vaccine in a Phase III Trial in Kolkata, India.PLoS One. 2014 May 6;9(5):e96499. Pubmed
  3. Desai SN, Cravioto A, Sur D, Kanungo S. Maximizing protection from use of oral cholera vaccines in developing country settings: An immunological review of oral cholera vaccines. Hum VaccinImmunother. 2014 May 26;10(6). Pubmed
  4. Kanungo S, Sen B, Ramamurthy T, Sur D, Manna B, Pazhani GP, Chowdhury G, Jhunjhunwala P, Nandy RK, Koley H, Bhattacharya MK, Gupta S, Goel G, Dey B, M T, Nair GB, Ghosh A, Mahalanabis D. Safety and Immunogenicity of a Live Oral Recombinant Cholera Vaccine VA1.4: A Randomized, Placebo Controlled Trial in Healthy Adults in a Cholera Endemic Area in Kolkata, India. PLoS One. 2014 Jul 1;9(7):e99381. Pubmed
  5. Dhingra MS, Kundu R, Gupta M, Kanungo S, Ganguly N, Singh MP, Bhattacharya MK, Ghosh R, Kumar R, Sur D, Chadha SM, Saluja T. Evaluation of safety and immunogenicity of a live attenuated tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus vaccine (BRV-TV) in healthy Indian adults and infants. Vaccine. 2014 Aug 11; 32 Suppl 1:A117-23. Pubmed
  6. Bhattacharya MK, Kanungo S, Ramamurthy T, Rajendran K, Sinha A, Bhattacharya A, Sharma Sarkar B. Comparison between Single Dose Azithromycin and Six Doses, 3 Day Norfloxacin for Treatment of Cholera in Adult. Int J Biomed Sc. 2014 Dec 10 (4): 248-51. Pubmed

2013

  1. Ali M, Sur D, You YA, Kanungo S, Sah B, Manna B, Puri M, Wierzba TF, Donner A, Nair GB, Bhattacharya SK, Dhingra MS, Deen JL, Lopez AL, Clemens J. Herd protection by a bivalent-killed-whole-cell oral cholera vaccine in the slums of Kolkata, India. Clin Infect Dis. 2013 Apr;56(8):1123-31. Pubmed
  2. Manna B, Nasrin D, Kanungo S*, Roy S, Ramamurthy T, Kotloff KL, Levine MM, Sur D. Determinants of Health Care Seeking for Diarrheal Illness in Young Children in Urban Slums of Kolkata, India.Am J Trop Med Hyg. 2013 Jul;89(1 Suppl):56-61. Pubmed
  3. Kanungo S, Mahapatra T, Bhaduri B, Mahapatra S, Chakraborty ND, Manna B, Sur D. Diarrhoea-related knowledge and practice of physicians in urban slums of Kolkata, India.Epidemiol Infect. 2014 Feb;142(2):314-26. Pubmed
  4. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, Faruque AS, Zaidi AK, Saha D, Alonso PL, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ochieng JB, Omore R, Oundo JO, Hossain A, Das SK, Ahmed S, Qureshi S, Quadri F, Adegbola RA, Antonio M, Hossain MJ, Akinsola A, Mandomando I, Nhampossa T, Acàcio S, Biswas K, O'Reilly CE, Mintz ED, Berkeley LY, Muhsen K, Sommerfelt H, Robins-Browne RM, Levine MM. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013 Jul 20;382(9888):209-22. Pubmed
  5. Bhattacharya SK, Sur D, Dutta S, Kanungo S, Ochiai RL, Kim DR, Anstey NM, von Seidlein L, Deen J. Vivax malaria and bacteraemia: a prospective study in Kolkata, India.Malar J. 2013 May 31;12(1):176. Pubmed
  6. You YA, Ali M, Kanungo S, Sah B, Manna B, Puri M, Nair GB, Bhattacharya SK, Convertino M, Deen JL, Lopez AL, Wierzba TF, Clemens J, Sur D. Risk map of cholera infection for vaccine deployment: the eastern Kolkata case.PLoS One. 2013 Aug 2;8(8):e71173. Pubmed
  7. Bhattacharya SK, Sur D, Ali M, Kanungo S, You YA, Manna B, Sah B, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Dhingra MS, Donner A, Nair GB, Lopez AL, Wierzba TF, Clemens JD. 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.Lancet Infect Dis. 2013 Dec;13(12):1050-6. Pubmed
  8. Kanungo S, Chakrabarti MK. Enteric Disease and Prevention: Where we stand? Everyman's Sci. 2013 Jun; XLVIII (2) : 87-88. Pubmed

2012

  1. Kanungo S, Sur D. Cholera and its vaccines. Paed Infect Dis 2012 Jan; 4(1),pp 18-24.
  2. Sarkar BL, Kanungo S, NairG.B. How endemic is cholera in India? Indian J Med Res 135, February 2012, pp 246-248. Pubmed
  3. Deb AK, Kanungo S, Deb M, Nair GB. Impact of climate change on health and strategies for mitigation and adaptation. WHO South-East Asia Journal of Public Health 2012;1(1):8-19 Pubmed
  4. Palit A, Batabyal P, Kanungo S, Sur D. In-house contamination of potable water in urban slum of Kolkata, India: a possible transmission route of diarrhea.Water Sci Technol. 2012;66(2):299-303. Pubmed
  5. Sinha A, Sengupta S, Ghosh S, Basu S, Sur D, Kanungo S, Mukhopadhyay AK, Ramamurthy T, Nagamani K, Rao MN, Nandy RK Evaluation of a rapid dipstick test for identifying cholera cases during the outbreak..Indian J Med Res. 2012 Apr;135(4):523-8. Pubmed
  6. Kanungo S, Sur D, Ali M, You YA, Pal D, Manna B, Niyogi SK, Sarkar B, Bhattacharya SK, Clemens JD, Nair GB. Clinical, epidemiological, and spatial characteristics of Vibrio parahaemolyticus diarrhea and cholera in the urban slums of Kolkata, India. BMC Public Health. 2012 Sep 28;12(1):830. Pubmed

2011

  1. Ganesh B, Nagashima S, Ghosh S, Nataraju SM, Rajendran K, Manna B, Ramamurthy T, Niyogi SK, Kanungo S, Sur D, Kobayashi N, Krishnan T. Detection and molecular characterization of multiple strains of Picobirnavirus causing mixed infection in a diarrhoeic child: Emergence of prototype Genogroup II-like strain in Kolkata, India. Int J MolEpidemiol Genet. 2011 Jan 1;2(1):61-72. Pubmed
  2. Deb AK, Kanungo S, Nair GB, Narain JP. The challenge of pneumonia acute diarrhoea at global, regional national levels: Time to refocus on a top most priority health problem. Indian J Med Res 133, February 2011, pp 128-30. Pubmed
  3. Kanungo S, Deb AK, Palit A, Nair GB. Impact of Climate Change on Diarrhoeal diseases, especially cholera, in India. Proceedings of the South East Asia Regional Conference on Epidemiology; 2010 Mar 8-10; New Delhi, India. World Health Organization; 2011. p. 246-51.
  4. Bhattacharya K, Kanungo S*, Sur D, Lal Sarkar B, Manna B, Lopez AL, Bhattacharya M, Nandy S, Kumar Niyogi S. Tetracycline -Resistant Vibrio cholerae O1, Kolkata, India. Emerg Infect Dis. 2011 Mar; 17(3):568-9. Pubmed
  5. Gupta SS, Mohammed MH, Ghosh TS, Kanungo S, Nair GB, Mande SS. Metagenome of the gut of a malnourished child. Gut Pathog. 2011 May 20;3(1):7. Pubmed
  6. Ali M, Sur D, Kim DR, Kanungo S, Bhattacharya SK, Manna B, Ochiai RL, Clemens J. Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India. Vaccine. Sep 2011 29; 9051-56. Pubmed
  7. Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Thu Van N, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL. Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoSNegl Trop Dis. 2011 Oct;5(10):e1289. Pubmed

2010

  1. Kanungo S, Sah BK, Lopez AL, Sung JS, Paisley AM, Sur D, Clemens JD, Nair GB.Cholera in India: an analysis of reports, 1997-2006.Bull World Health Organ2010;88:185-191. Pubmed
  2. Kanungo S, Tsuzuki A, Deen JL, Lopez AL , Rajendran K , Manna B, Sur D, Kim D R, Gupta VK, Ochiai RL, Ali M, Seidlein Lorenz von , Bhattacharya SK , Clemens JD. Verbal autopsy to determine causal, age, and gender mortality patterns in an urban slum in Kolkata, India. Bull World Health Organ. 2010 Sep 1;88(9):667-74. Pubmed
  3. Ganesh B, Nataraju SM, Rajendran K, Ramamurthy, T, Kanungo S, Manna B, Nagashima, S, Sur D, Kobayashi N, Krishnan T. Detection of closely related Picobirnaviruses among diarrhoeic children in Kolkata: - evidence of zoonoses? Infect Genet Evol. 2010 May;10(4):511-6. Epub 2010 Feb 21. Pubmed
  4. Ali M, Sur D, Lopez AL, Kanungo S, Ochiai RL, Manna B, Kim DR, Deen J, Bhattacharya SK, Clemens JD. Community participation in two vaccination trials in the slums of Kolkata, India: spatial and multilevel analyses. J Health PopulNutr 2010 Oct;28(5):450-457. Pubmed
  5. Nair GB, PalitA,Deb AK and Kanungo S. Evaluating prospectively the impact of climate change on the occurrence of diarrhoeal diseases with emphasis on cholera: A generic research protocol. World Health Organization 2010. SEA-CD-207.
  6. Bhattacharya MK, Kanungo S, Palit A, Chatterjee S, Ghosh M, Seth BC, Dutta KK, Kundu P, Bhattacharya SK. Study of Socio-economic Background of HV/AIDS patients in West Bengal, India. Ind J Physiol& Allied Sci. 2010 Vol 64 (1) Pp 2-9.

2009

  1. Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, Manna B, Dutta S, Donner A, Kanungo S, Park JK, Puri MK, Kim DR, Dutta D, Bhaduri B, Acosta CJ, Clemens JD. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med. 2009 Jul 23;361(4):335-44. Pubmed
  2. Kanungo S, Paisley A, Bhattacharya MK, Lopez AL, Manna B, Han SH, Kim DR, Carbis R, Rao R, Clemens JD, Sur D. Immune responses following one and two doses of the bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata India: A randomized, placebo controlled trial. Vaccine, 2009 Nov 16;27(49):6887-93. Pubmed
  3. Kanungo S, Sur D, Nair GB. Vaccination against Cholera; opening a new horizon of hope? Sevamed July 2009 Vol.8 No.3
  4. Sur D, Manna B, Chakrabarty N, Kaljee LM, Riel R, Pach A, Kanungo S, Deen J, Ochiai RL, Clemens J, Bhattacharya SK. Vaccine desirability during an effectiveness trial of the typhoid fever polysaccharide Vi vaccine, Kolkata India. Hum Vaccines. 2009 Sep;5(9):614-20. Pubmed
  5. Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar BL, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Van NT, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. The Lancet 2009 Nov 14; 374 (9702):1694 - 1702. Pubmed
  6. Sur D ,Chatterjee S, Riewpaiboon A, Manna B, Kanungo S ,Bhattacharya SK. Treatment Cost for Typhoid Fever at Two Hospitals in Kolkata, India. J Health PopulNutr 2009 Dec; 27(6):725-732. Pubmed

2008

  1. Mahalanabis D, Lopez AL, Sur D, Deen J, Manna B, Kanungo S, von Seidlein L, Carbis R, Han SH, Shin SH, Attridge S, Rao R, Holmgren J, Clemens J, Bhattacharya SK. A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS ONE. 2008 Jun 4;3(6):e2323. Citation : 28, Pubmed
  2. Kanungo S, Dutta S, Sur D. Epidemiology of typhoid and paratyphoid fever in India. J Infect Developing Countries 2008; 2(6): 454-460. Pubmed
  3. Dutta S, Deen JL, Sur D, Manna B, Kanungo S, Bhaduri B, Lopez AL, von SeidleinL,Clemens JD, Bhattacharya SK. Increased utilization of treatment centre facilities during a dengue fever outbreak in Kolkata, India. Dengue Bulletin 2008Vol 32 162-5.

2006

  1. Sur D, Sarkar BL, Manna B, Deen JL, Datta S, Niyogi SK, Ghosh AN, Deb AK, Kanungo S, Palit A, SK Bhattacharya.Epidemiological, microbiological electron microscopic study of a cholera outbreak in a Kolkata slum community. Indian J Med Res.2006 Jan ;123:31-6. Pubmed
  2. Sur D, Seidlein L von, Manna B, Dutta S, Deb AK, Sarkar BL, Kanungo S, Deen JL, Ali M, Kim DR, Gupta VK, Ochiai RL, TsuzukiA, Acosta CJ, Clemens JD, Bhattacharya SK. The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study.Trans R Soc Trop Med Hyg. 2006 Aug;100(8):725-33. Pubmed

2005

  1. Sur D, Deen JL, Manna B, Niyogi SK, Deb AK, Kanungo S, Sarkar BL, Kim DR, Danovaro-Holliday MC, Holliday K, Gupta VK, Ali M, Seidlein L von, Clemens JD, Bhattacharya SK The burden of Cholera in the slums of Kolkata, India: Data from a prospective, community based study:. Arch Dis Child. 2005 Nov ;90:1175-81. Pubmed

Book Chapters

  1. Sur D, Kanungo S. Climate sensitive diseases: Diarrhoeal Diseases. In (eds) NitishDogra, Sangeet Srivastava) Understanding the link between planetary and population health Ed: TERI Press.2010. pp 219-30.
  2. Dutta S, Kanungo S, Sur D. Effect of microbiological pollution of drinking water on human health and remedy. Ed: AndriyLutsenko and Vasyl Palahniuk© 2009 Nova Science Publishers, Inc. ISBN: 978-1-60741-273-1 pp.321-337.

Others

  1. Kanungo S, Amarasinghe A, Sur D, Manna B, Chatterjee S, Sadhukhan P, Dutta S, Beatty M E, Letson B, Margolis H, Chakrabarty S. Surveillance for dengue fever in Eastern Kolkata, West Bengal, India: preliminary results. IMED, Vienna in 2009
  2. Kanungo S, Amarasinghe A, Beatty ME, Sur D, Manna B, Chatterjee S, Sadhukhan P, Dutta S, Chakrabarty S. Burden of Dengue fever in Eastern Kolkata, India: data from a prospective community based study. The 3rd World Vaccine Congress at Singapore Oct 4-6, 2009
  3. Kanungo S, Deb AK, Palit A, Nair GB. Impact of Climate Change on Diarrhoeal diseases, especially cholera, in India. Proceedings of the South East Asia Regional Conference on Epidemiology; 2010 Mar 8-10; New Delhi, India. World Health Organization; 2011. p. 246-51.
  4. Evaluation of the impact of climate change on the occurrence of diarrhoeal diseases with emphasis on cholera. Kanungo S, Deb AK, Palit A, Nair GB, performed APW (Agreement for performance of Work) for WHO-SEARO
  5. Relationship between climate variability and occurrence of diarrhea and cholera: A pilot study using retrospective data from Kolkata, India. Kanungo S, Deb AK, Palit A, Nair GB. Done in collaboration with WHO, Kobe